Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients

BACKGROUND: The prediction of therapy response in head and neck squamous cell cancer (HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy concepts. The current study aimed to identify therapy-responsive microRNAs (miRNAs) in the circulation that can serve as minimally...

Descripción completa

Detalles Bibliográficos
Autores principales: Summerer, I, Unger, K, Braselmann, H, Schuettrumpf, L, Maihoefer, C, Baumeister, P, Kirchner, T, Niyazi, M, Sage, E, Specht, H M, Multhoff, G, Moertl, S, Belka, C, Zitzelsberger, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647540/
https://www.ncbi.nlm.nih.gov/pubmed/26057452
http://dx.doi.org/10.1038/bjc.2015.111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647540/
https://www.ncbi.nlm.nih.gov/pubmed/26057452
http://dx.doi.org/10.1038/bjc.2015.111

Ejemplares similares